Insider Selling: Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Director Sells 33,942 Shares of Stock

Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Get Rating) Director Simon N. Pimstone sold 33,942 shares of the company’s stock in a transaction dated Monday, August 15th. The stock was sold at an average price of $37.76, for a total transaction of $1,281,649.92. Following the transaction, the director now owns 58,058 shares in the company, valued at […]

Related Keywords

Colorado ,United States ,Canada ,Simonn Pimstone , ,Xenon Pharmaceuticals Company Profile ,News Ratings For Xenon Pharmaceuticals Daily ,Nasdaq ,Xenon Pharmaceuticals Price Performance ,Xenon Pharmaceuticals ,Quarter For Xenon Pharmaceuticals ,Jpmorgan Chase Co ,Xenon Pharmaceuticals Inc ,Public Employees Retirement Association Of Colorado ,Institutional Trading Of Xenon Pharmaceuticals ,Advisory Research Inc ,Pura Vida Investments ,Get Rating ,Director Simon ,Employees Retirement Association ,Vida Investments ,Commodore Capital ,Pharmaceuticals Inc ,Xenon Pharmaceuticals Daily ,Nasdaq Xene ,Exene ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,